(Q24245104)

1

0 references

Susan J Brunskill

2

0 references

Peter W Soothill

3

0 references

David J Roberts

4

0 references

Michael F Murphy

Cochrane Database of Systematic Reviews

6

0 references

publication date

24 January 2005

0 references

published in

0 references

cites work

Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Antenatal management of alloimmune thrombocytopenia with intravenous γ-globulin: A randomized trial of the addition of low-dose steroid to intravenous γ-globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Antenatal treatment of neonatal alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Fetal alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Initial fetal platelet counts predict the response to intravenous gammaglobulin therapy in fetuses that are affected by PLA1 incompatibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Antenatal care in pregnancies at risk of alloimmune thrombocytopenia: report of 19 cases in 16 families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Neonatal alloimmune thrombocytopenia: antenatal management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA-5 alloantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Alloimmunization to the PlA1 platelet antigen: results of a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Intravenous fetal transfusion of immunoglobulin for alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Fetal thrombocytopenia and its relation to maternal thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids--more questions than answers. European Working Group on FMAIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Gene frequencies of the five major human platelet antigens in African American, white, and Korean populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Maternal intravenous immunoglobulin treatment does not prevent intracranial haemorrhage in fetal alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Intracranial haemorrhage in haemophilia A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Effect of IVIgG treatment on fetal platelet count, HPA-1a titre and clinical outcome in a case of feto-maternal alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Management of fetal alloimmune thrombocytopenia-a less invasive option?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

348 cases of suspected neonatal alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Management of fetal alloimmune thrombocytopenia by weekly in utero platelet transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Antenatal management of fetomaternal alloimmune thrombocytopenia--report of 15 affected pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Advances in the management of alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Continuing controversy in alloimmune thrombocytopenia: fetal hyperimmunoglobulinemia fails to prevent thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Serial aggressive platelet transfusion for fetal alloimmune thrombocytopenia: platelet dynamics and perinatal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Follow up of children after antenatal treatment for alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Human placental Fc receptors and the transmission of antibodies from mother to fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Gene frequencies of human platelet antigens on glycoprotein IIIa in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Long-term effects of fetal and neonatal alloimmune thrombocytopenia and its antenatal treatment on the medical and developmental outcomes of affected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

In-utero fetal therapy with immunoglobulin for alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

7 January 2021

Acute renal failure associated with immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

7 January 2021

Clinical uses of intravenous immunoglobulin in pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

7 January 2021

Prenatal treatment of alloimmune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

7 January 2021

In-utero platelet transfusion for alloimmune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

7 January 2021

Variable inhibition of placental IgG transfer in vitro with commercial IVgG preparations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

7 January 2021

Corticosteroids during pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

7 January 2021

Immunogenicity of and immune response to the human platelet antigen Zwa is strongly associated with HLA-B8 and DR3.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

7 January 2021

Distribution of human platelet antigens in a Chinese population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

7 January 2021

Failure of antenatal high-dose immunoglobulin to improve fetal platelet count in neonatal allo-immune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

7 January 2021

High-dose immunoglobulin in the antenatal treatment of neonatal alloimmune thrombocytopenia: case report and review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

7 January 2021

Neonatal alloimmune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004226.PUB2

7 January 2021